LEADER 01150nam0 22002891i 450 001 UON00399206 005 20231205104648.631 100 $a20111028d1937 |0itac50 ba 101 $ager 102 $aSE 105 $a|||| 1|||| 200 1 $aSlavisch-Baltisches in altnordischen Beinamen$fvon Karl Axnäs 210 $aUppsala$cAppelbergs$d1937 215 $a114 p.$d25 cm. 410 1$1001UON00399207$12001 $aNomina germanica$eArkiv för germansk namnforskning utgivet$fav Jöran Sahlgren.$v2 606 $aLINGUISTICA BALTO-SLAVA$3UONC039254$2FI 620 $aSE$dUppsala$3UONL000426 676 $a491.8$cLINGUE SLAVE$v21 676 $a491.9$cLINGUE BALTICHE$v21 700 1$aAXNAS$bKarl$3UONV204993$0402071 712 $aAppelbergs$3UONV248875$4650 801 $aIT$bSOL$c20240220$gRICA 899 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$2UONSI 912 $aUON00399206 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI SL FL 15 0123 $eSI MR 44994 5 0123 $sBuono 996 $aSlavisch-baltisches in altnordischen Beinamen$9570671 997 $aUNIOR LEADER 02232nam 2200505 450 001 9910830569903321 005 20231005114944.0 010 $a1-119-94106-7 035 $a(OCoLC)780063972 035 $a(CKB)3360000000455809 035 $a(NjHacI)993360000000455809 035 $a(BIP)037335827 035 $a(EXLCZ)993360000000455809 100 $a20231005d2013 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aExtreme Tissue Engineering $eConcepts and Strategies for Tissue Fabrication /$fRobert Brown 210 1$a[Place of publication not identified] :$cJohn Wiley & Sons, Inc.,$d2013. 215 $a1 online resource (xiv, 252 pages) $cillustrations 300 $aIncludes index. 311 $a0-470-97447-8 327 $aWhich tissue engineering tribe are you from? -- Checking out the tissue groupings and the small print -- What cells "hear" when we say "3D" -- Making support-scaffolds containing living cells -- Making the shapes for cells in support-scaffolds -- Asymmetry : 3D complexity and layer engineering: worth the hassle? -- Other ways to grow tissues? -- bioreactors and all that bio-engineering jazz -- Towards 4D fabrication : time, monitoring, function and process dynamics. 330 $aHighly Commended at the BMA Book Awards 2013 Extreme Tissue Engineering is an engaging introduction to Tissue Engineering and Regenerative Medicine (TERM), allowing the reader to understand, discern and place into context the mass of scientific, multi-disciplinary data currently flooding the field. 517 $aExtreme Tissue Engineering 606 $aTissue engineering 606 $aCell culture 606 $aRegenerative medicine 606 $aTissue scaffolds 610 $aTissue Culture 610 $aScience 615 0$aTissue engineering. 615 0$aCell culture. 615 0$aRegenerative medicine. 615 0$aTissue scaffolds. 676 $a610.28 700 $aBrown$b Robert$0362993 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910830569903321 996 $aExtreme Tissue Engineering$94085318 997 $aUNINA LEADER 01546oam 2200505zu 450 001 9910693524103321 005 20251017110109.0 035 $a(CKB)3450000000002030 035 $a(SSID)ssj0000578174 035 $a(PQKBManifestationID)12195820 035 $a(PQKBTitleCode)TC0000578174 035 $a(PQKBWorkID)10577297 035 $a(PQKB)22160637 035 $a(OCoLC)46636714 035 9 $aocm46636714 035 $a(OCoLC)993450000000002030 035 $a(DNLM)1124252 035 $a(EXLCZ)993450000000002030 100 $a20160829d2001 uy 101 0 $aeng 135 $aurun|||||| 181 $ctxt 182 $cc 183 $acr 200 10$aManagement of acute otitis media 210 31$a[Place of publication not identified]$cAHRQ$d2001 225 1 $aEvidence report/technology assessment. Summary ;$vno. 15 225 1 $aAHRQ publication ;$vno. 00-E 008 300 $aBibliographic Level Mode of Issuance: Monograph 606 $aOtitis Media$xdrug therapy 606 $aAmoxicillin$xtherapeutic use 606 $aChild 606 $aEvaluation Studies as Topic 615 12$aOtitis Media$xdrug therapy. 615 22$aAmoxicillin$xtherapeutic use. 615 22$aChild. 615 22$aEvaluation Studies as Topic. 700 $aMarcy$b Michael$01351401 702 $aTakata$b Glenn 712 02$aUnited States Agency for Healthcare Research and Quality 801 0$bPQKB 906 $aBOOK 912 $a9910693524103321 996 $aManagement of acute otitis media$93103855 997 $aUNINA